{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:32:55Z","timestamp":1778290375633,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-024-04169-4","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T12:03:07Z","timestamp":1722427387000},"page":"63-69","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The effect of intravesical chemohyperthermia with mitomycin in non-muscle-invasive bladder tumour patients who cannot tolerate BCG treatment or recur after treatment and refuse cystectomy"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8651-9406","authenticated-orcid":false,"given":"Enes Malik","family":"Akda\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7617-7529","authenticated-orcid":false,"given":"Mustafa Melih","family":"\u00c7ulha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7786-3432","authenticated-orcid":false,"given":"Engin","family":"Telli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8412-577X","authenticated-orcid":false,"given":"Efe","family":"Bosnal\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9852-4229","authenticated-orcid":false,"given":"Serdar","family":"Baykal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2414-6499","authenticated-orcid":false,"given":"Enes Abdullah","family":"Baynal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-4662","authenticated-orcid":false,"given":"Kerem","family":"Teke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4151-5193","authenticated-orcid":false,"given":"\u00d6nder","family":"Kara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"issue":"4","key":"4169_CR1","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.juro.2009.06.017","volume":"182","author":"O Nativ","year":"2009","unstructured":"Nativ O, Witjes JA, Hendricksen K et al (2009) Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin. J Urol 182(4):1313\u20131317","journal-title":"J Urol"},{"issue":"2","key":"4169_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0022-5347(17)32741-6","volume":"152","author":"RB Nadler","year":"1994","unstructured":"Nadler RB, Catalona WJ, M\u2019liss AH et al (1994) Durability of the tumor-free response for intravesical bacillus Calmette-Guerin therapy. J Urol 152(2):367\u2013373","journal-title":"J Urol"},{"key":"4169_CR3","doi-asserted-by":"publisher","first-page":"775527","DOI":"10.3389\/fsurg.2021.775527","volume":"8","author":"H Zhao","year":"2021","unstructured":"Zhao H, Chan VW, Castellani D et al (2021) Intravesical chemohyperthermia vs. bacillus Calmette-Guerin Instillation for intermediate- and high-risk non-muscle invasive bladder cancer: a systematic review and meta-analysis. Front Surg. 8:775527","journal-title":"Front Surg."},{"issue":"1","key":"4169_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1470-2045(05)70472-1","volume":"7","author":"SM Di Stasi","year":"2006","unstructured":"Di Stasi SM, Giannantoni A, Giurioli A et al (2006) Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial. Lancet Oncol 7(1):43\u201351","journal-title":"Lancet Oncol"},{"issue":"6","key":"4169_CR5","first-page":"497","volume":"83","author":"WS Tan","year":"2023","unstructured":"Tan WS, Prendergast A, Ackerman C et al (2023) Adjuvant intravesical chemohyperthermia versus passive chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer (HIVEC-II): a phase 2, open-label. Random Control Trial Eur Urol 83(6):497\u2013504","journal-title":"Random Control Trial Eur Urol"},{"issue":"3","key":"4169_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.juro.2014.03.101","volume":"192","author":"TJ Arends","year":"2014","unstructured":"Arends TJ, van der Heijden AG, Witjes JA (2014) Combined chemohyperthermia: 10\u00a0year single center experience in 160 patients with nonmuscle invasive bladder cancer. J Urol 192(3):708\u2013713","journal-title":"J Urol"},{"issue":"23","key":"4169_CR7","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1200\/JCO.2003.01.089","volume":"21","author":"R Colombo","year":"2003","unstructured":"Colombo R, Da Pozzo LF, Salonia A et al (2003) Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 21(23):4270\u20134276","journal-title":"J Clin Oncol"},{"issue":"1","key":"4169_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eururo.2011.04.023","volume":"60","author":"RJ Lammers","year":"2011","unstructured":"Lammers RJ, Witjes JA, Inman BA et al (2011) The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review. Eur Urol 60(1):81\u201393","journal-title":"Eur Urol"},{"key":"4169_CR9","first-page":"e1123","volume":"203","author":"A Sousa","year":"2020","unstructured":"Sousa A, Gonzalez-Valc\u00e1rcel I, Mata JL et al (2020) MP73-06 chemo-resection with hyperthermic intravesical instillation (hivec-r) vs standard treatment in patients with intermediate-high risk nmibc comparative prospective randomized controled study of efficacy and tolerability preliminary results. J Urol 203:e1123\u2013e1123","journal-title":"J Urol"},{"issue":"6","key":"4169_CR10","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.eururo.2016.01.006","volume":"69","author":"TJ Arends","year":"2016","unstructured":"Arends TJ, Nativ O, Maffezzini M et al (2016) Results of a randomised controlled trial comparing intravesical chemohyperthermia with mitomycin C versus bacillus Calmette-Gu\u00e9rin for adjuvant treatment of patients with intermediate-and high-risk non\u2013muscle-invasive bladder cancer. Eur Urol 69(6):1046\u20131052","journal-title":"Eur Urol"},{"key":"4169_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.semcancer.2016.03.004","volume":"37\u201338","author":"T Mantso","year":"2016","unstructured":"Mantso T, Goussetis G, Franco R et al (2016) Effects of hyperthermia as a mitigation strategy in DNA damage-based cancer therapies. Semin Cancer Biol 37\u201338:96\u2013105","journal-title":"Semin Cancer Biol"},{"key":"4169_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.critrevonc.2015.08.003","volume":"97","author":"M Mallory","year":"2016","unstructured":"Mallory M, Gogineni E, Jones GC et al (2016) Therapeutic hyperthermia: the old, the new, and the upcoming. Crit Rev Oncol Hematol 97:56\u201364","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"4169_CR13","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/jnci\/60.3.711","volume":"60","author":"CW Song","year":"1978","unstructured":"Song CW (1978) Effect of hyperthermia on vascular functions of normal tissues and experimental tumors: brief communication. J Natl Cancer Inst 60(3):711\u2013713","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"4169_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41585-018-0092-z","volume":"15","author":"WS Tan","year":"2018","unstructured":"Tan WS, Kelly JD (2018) Intravesical device-assisted therapies for non-muscle-invasive bladder cancer. Nat Rev Urol 15(11):667\u2013685","journal-title":"Nat Rev Urol"},{"key":"4169_CR15","unstructured":"Available: https:\/\/uroweb.org\/guidelines\/non-muscle-invasive-bladder-cancer\/chapter\/disease-management. Accessed 03 February 2024."},{"issue":"4","key":"4169_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nrurol.2017.16","volume":"14","author":"AM Kamat","year":"2017","unstructured":"Kamat AM, Colombel M, Sundi D et al (2017) BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG. Nat Rev Urol 14(4):244\u2013255","journal-title":"Nat Rev Urol"},{"issue":"1","key":"4169_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.eururo.2018.09.005","volume":"75","author":"WS Tan","year":"2019","unstructured":"Tan WS, Panchal A, Buckley L et al (2019) Radiofrequency-induced thermo-chemotherapy effect versus a second course of bacillus Calmette-Gu\u00e9rin or institutional standard in patients with recurrence of non\u2013muscle-invasive bladder cancer following induction or maintenance bacillus Calmette-Gu\u00e9rin therapy (HYMN): a phase III, open-label, randomised controlled trial. Eur Urol 75(1):63\u201371","journal-title":"Eur Urol"},{"key":"4169_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.urology.2020.10.039","volume":"149","author":"GE Koch","year":"2021","unstructured":"Koch GE, Smelser WW, Chang SS (2021) Side effects of intravesical BCG and chemotherapy for bladder cancer: what they are and how to manage them. Urology 149:11\u201320","journal-title":"Urology"},{"key":"4169_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1464-410X.2012.11619.x","volume":"110","author":"C Logan","year":"2012","unstructured":"Logan C, Brown M, Hayne D (2012) Intravesical therapies for bladder cancer\u2013indications and limitations. BJU Int 110:12\u201321","journal-title":"BJU Int"},{"issue":"4","key":"4169_CR20","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1097\/01.ju.0000146274.85012.e1","volume":"173","author":"AG van der Heijden","year":"2005","unstructured":"van der Heijden AG, Verhaegh G, Jansen CFJ et al (2005) Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study. J Urol 173(4):1375\u20131380","journal-title":"J Urol"},{"issue":"3","key":"4169_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.0306-5251.2001.01449.x","volume":"52","author":"R Paroni","year":"2001","unstructured":"Paroni R, Salonia A, Lev A et al (2001) Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma. Br J Clin Pharmacol 52(3):273\u2013278","journal-title":"Br J Clin Pharmacol"},{"key":"4169_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00280-014-2381-4","volume":"73","author":"P Milla","year":"2014","unstructured":"Milla P, Fiorito C, Soria F et al (2014) Intravesical thermo-chemotherapy based on conductive heat: A first pharmacokinetic study with mitomycin C in superficial transitional cell carcinoma patients. Cancer Chemother Pharmacol 73:503\u2013509","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"4169_CR23","first-page":"62.e13","volume":"40","author":"OM Pijpers","year":"2022","unstructured":"Pijpers OM, Hendricksen K, Mostafid H et al (2022) Long-term efficacy of hyperthermic intravesical chemotherapy for BCG-unresponsive non-muscle invasive bladder cancer. Urol Oncol Semin Orig Investig 40(2):62.e13-62.e20","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"4169_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/BLC-180191","volume":"4","author":"JJ de Jong","year":"2018","unstructured":"de Jong JJ, Hendricksen K, Rosier M et al (2018) Hyperthermic intravesical chemotherapy for BCG unresponsive non-muscle invasive bladder cancer patients. Bladder Cancer 4:395\u2013401","journal-title":"Bladder Cancer"},{"issue":"4","key":"4169_CR25","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.eururo.2014.05.033","volume":"66","author":"JR Oddens","year":"2014","unstructured":"Oddens JR, Sylvester RJ, Brausi MA et al (2014) The effect of age on the efficacy of maintenance bacillus Calmette\u2013Gu\u00e9rin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911. Eur Urol 66(4):694\u2013701","journal-title":"Eur Urol"},{"issue":"5","key":"4169_CR26","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3390\/cancers15051455","volume":"15","author":"V Anastay","year":"2023","unstructured":"Anastay V, Baboudjian M, Masson-Lecomte A et al (2023) Is CIS a contraindication to hyperthermic intravesical chemotherapy (HIVEC) after BCG-failure? Cancers 15(5):1455","journal-title":"Cancers"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04169-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-024-04169-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04169-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T03:08:39Z","timestamp":1735873719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-024-04169-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["4169"],"URL":"https:\/\/doi.org\/10.1007\/s11255-024-04169-4","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"assertion":[{"value":"22 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}